Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come ...

CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...

Other health insurers in the S&P 500, including Humana, Molina Healthcare and Cigna, saw their stock prices decline. Companies in the broader healthcare space, including Elevance Health, Centene and ...

UnitedHealth Group shares plunged in premarket trading as the firm announced a surprise exit of the current CEO and pulled its full-year forecast.

Key Takeaways The S&P 500 rose 3.3% on Monday, May 12, 2025, as investors reviewed a trade deal between the U.S. and China ...

President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his executive order on drug pricing, saying he would cut them out as part of a goal ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit ...

CVS Health (CVS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one ...

Stock indexes settle moderately higher on Thursday ... although that was stronger than expectations of a larger decline to 47.9. The Apr ISM prices paid sub-index rose +0.4 to a 2-3/4 year high of ...

CVS) stands against the other stocks to buy and hold for 10 years. When the stock market experiences a sharp decline, as it did after the Trump administration announced tariffs on its trade ...